1Hacke W, Kaste M, Bluhmki E. Thrombolysis with aheplase 3 to 4.5 hours after acute ischemic stroke[J]. N Engl J Med,2008, 359 : 1317-1329.
2Zhaorong W, Yueju W, Gangqiang L. Optimized gene synthesis, expression and purifi cation of active salivary plasminogen activator α2 (DSPAα2) of Desmodus rotundus in Pichia pastoris[J]. Protein Expres Purif,2008,57 (1) :27-33.
3Schiermeyer A,Sehinkel H, Apel S, et al. Production of Desmodus rotundas salivary plasminogen activator alpha 1 ( DSPA alpha 1 ) in tobacco is hampered by proteolysis [J]. Biotechnol Bioeng, 2005,89(7) :848-858.
4Schleuning W D,Alagon A, Boidol W, et al. Plasminogen activators from the saliva of Desmodus rotundus ( common vampire bat) : unique fibrin specificity. [ J ]. Ann N Y Acad Sci, 1992,667:395- 403.
5Witt W, Baldus B, Bringmann P, et al. Thrombolytic properties of desmodus rotundus ( vampire bat) salivary plasminogen activator in experimental pulmonary embolism in rats [ J ]. Blood, 1992,79 (5) :1213-1217.
6Witt W, Maass B, Baldus B, et al. Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration [ J ]. Circulation, 1994,90 ( 1 ) :421-426.
7Kruithof E K, Schleuning W D. A comparative study of amyloid-beta ( 1-42 ) as a cofactor for plasminogen activation by vampire bat plasminogen activator and recombinant human tissue-type plasminogen activator[J]. Thromb Haemost,2004,92(3):559-567.
8Gulba D, Praus M, Dechend R, et al. Update on the toxicology and pharmacology of rDSPA alpha 1 (bat-PA) in animals and humane [J]. Fibrinoiysis Proteolysis, 1997,11 (2) :55-62.
9Reddrop C, Moldrich R, Beart P. Vampire bat salivary plasminogen activator (Desmoteplase) inhibits tissue-type plasminogen activity- induced potential of exeitotoxie injury[ J ]. Stroke ,2005,36 : 1241- 1246.
10Gabriel T, Samson A, Bladin C, et al. Vampire hat salivary plasminogen activator (desmoteplase) : a unique fibrinolytic enzyme that does not promote neurodegencration [J]. Stroke, 2003,34 : 537-543.
8Van de Werf F,Nobuhara M,Collen D.Coronary thrombolysis with human single-chain,urokinase-type plasminogen activator(prourokinase)in patients with acute myocardial infarction[J].Ann Intern Med,1986,104(3):345-348.
9FlohéL.Single-chain urokinase-type plasminogen activators:new hopes for clot-specific lysis[J].Eur Heart,1985,6(11):905-908.
10Lijnen HR,Collen D.Mechanisms of plasminogen activation by mammalian plasminogen activators[J].Enzyme,1998,40(2/3):90-96.
